Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Plos Pathogens
|
June 1, 2011
Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA
Matthew S Lalonde, Michael A Lobritz, Annette Ratcliff, et al.
Science Advances
|
December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1
Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.
Journal of Molecular Biology
|
February 6, 2004
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"
Ben Davis, Mohammad Afshar, Gabriele Varani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2021
Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging
Sara Gianella, Stephen A Rawlings, Curtis Dobrowolski, et al.
Mbio
|
February 5, 2026
Reduction of the HIV-1 reservoir in T cells from people with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells
Mary Ann Checkley, Benjamin G Luttge, Cheryl M Cameron, et al.
Open Forum Infectious Diseases
|
January 15, 2026
Longitudinal T-Cell Phenotypic Dynamics During Sustained Antiretroviral Therapy in People With HIV
Christophe Vanpouille, Alan Wells, Victor DeGruttola, et al.
Plos One
|
May 19, 2016
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial
Deepti Saxena, Michael Spino, Fernando Tricta, et al.
Cell Reports
|
February 15, 2023
Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains
Mona Rheinberger, Ana Luisa Costa, Martin Kampmann, et al.
Journal of Molecular Biology
|
April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA
Alastair I H Murchie, Ben Davis, Catherine Isel, et al.
Nature Communications
|
June 9, 2023
A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon
Debjit Khan, Fulvia Terenzi, GuanQun Liu, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Plos Pathogens
|
June 1, 2011
Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA
Matthew S Lalonde, Michael A Lobritz, Annette Ratcliff, et al.
Science Advances
|
December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1
Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.
Journal of Molecular Biology
|
February 6, 2004
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"
Ben Davis, Mohammad Afshar, Gabriele Varani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2021
Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging
Sara Gianella, Stephen A Rawlings, Curtis Dobrowolski, et al.
Mbio
|
February 5, 2026
Reduction of the HIV-1 reservoir in T cells from people with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells
Mary Ann Checkley, Benjamin G Luttge, Cheryl M Cameron, et al.
Open Forum Infectious Diseases
|
January 15, 2026
Longitudinal T-Cell Phenotypic Dynamics During Sustained Antiretroviral Therapy in People With HIV
Christophe Vanpouille, Alan Wells, Victor DeGruttola, et al.
Plos One
|
May 19, 2016
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial
Deepti Saxena, Michael Spino, Fernando Tricta, et al.
Cell Reports
|
February 15, 2023
Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains
Mona Rheinberger, Ana Luisa Costa, Martin Kampmann, et al.
Journal of Molecular Biology
|
April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA
Alastair I H Murchie, Ben Davis, Catherine Isel, et al.
Nature Communications
|
June 9, 2023
A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon
Debjit Khan, Fulvia Terenzi, GuanQun Liu, et al.
Page
of 8